Background: In an attempt to improve the cytogenetic and molecular response rate in Philadelphia chromosome–positive early chronic-phase CML, we compared the combination of imatinib plus low ...

Suppression of Philadelphia chromosome positivity has been ... Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology ...

Philadelphia chromosome-positive acute lymphoblastic leukemia—current concepts and future perspectives. Rev Clin Exp Hematol 2002; 6: 142–160.

Nowell and Hungerford started their search by investigating cells from individuals with acute myelogenous leukemia ... This chromosome was soon dubbed the "Philadelphia chromosome," named after ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

PHYRAGO™ is indicated for adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and adult patients with Philadelphia chromosome ...

Bosulif is used to treat: chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (CML) that is newly diagnosed or did not respond to previous treatment in adults and certain ...

Novartis (NVS) announced “positive,” longer-term results ... in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase at the week ...

Phyrago is indicated for adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (Ph+ CML) in chronic phase and adult patients with Philadelphia chromosome ...